Teleflex Incorporated reported second-quarter sales of US$570.33 million but lower net income of US$99.69 million year-on-year, and cut its 2026 GAAP EPS guidance to US$2.54 to US$2.84 while affirming revenue guidance of US$2.26 billion to US$2.28 billion. The company also completed a US$250 million repurchase of 1,900,000 shares and affirmed a quarterly US$0.34 dividend payable on September 30, 2026. The lowered earnings outlook and extended integration timelines for the Vascular Intervention acquisition are sharpening investor focus on how Teleflex converts its portfolio reshaping into sustainable profitability and cash returns.
Teleflex IncorporatedTeleflex cut its 2026 GAAP EPS guidance to $2.54-$2.84, reflecting weaker Q2 net income and extended integration timelines for the Vascular Intervention acquisition.
